Template:Ergotamine: Difference between revisions

Revision as of 22:54, 11 February 2014

ERGOMAR (ergotamine tartrate) tablet
ERGOMAR (ergotamine tartrate) tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
ERGOMAR (ergotamine tartrate) tablet
ZZZZZ^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on XXXXX
ClinicalTrials.gov

@@ Line 1: / Line 1: @@
 {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
-! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[ERGOMAR (ergotamine tartrate) tablet|{{fontcolor|#6C7B8B|ERGOMAR (ergotamine tartrate) tablet}}]]'''''
+! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ergotamine|{{fontcolor|#6C7B8B|ERGOMAR (ergotamine tartrate) tablet}}]]'''''
 |-
 ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ERGOMAR (ergotamine tartrate) tablet<sup>®</sup> FDA Package Insert